The Journal of Managed Care Pharmacy, the official publication of the Academy of Managed Care Pharmacy, has published a PHAR and GlaxoSmithKline authored paper entitled "Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. The paper describes the cost and health service utilization associated with asthma and COPD in a population of Medicare beneficiaries.

Two PHAR abstracts, "Assessment of Healthcare Utilization Associated with Integrated Healthcare Association's Pay For Performance (P4P) Asthma Measure, Appropriate Use of Rescue Inhalers" and "Assessment of Healthcare Utilization Associated with Integrated Healthcare Association's Pay For Performance (P4P) Asthma Measure, Appropriate Use of Rescue Inhalers," have been accepted for oral presentation at the 2008 meeting of the American Academy of Allergy, Asthma, and Immunology (AAAAI), to be held March 14-18, 2008 in Philadelphia, PA. Both abstracts will be published in the February 2008 supplement to The Journal of Allergy and Clinical Immunology.

PHAR's poster "Persistence and Compliance with Omalizumab and Other Asthma Controller Medications within a Managed-Care Population" was selected as "The Best of Healthcare Education, Delivery and Quality (HCEDQ)" at the 2007 Annual American Academy of Allergy Asthma and Immunology (AAAAI) meeting.